Dopamine receptor mapping with PET imaging in Parkinson’s disease

Neural response to visual sexual cues in dopamine treatment-linked hypersexuality in Parkinson’s disease

(2013) Marios Politis et al.   BRAIN

Treadmill exercise elevates striatal dopamine D2 receptor binding potential in patients with early Parkinson’s disease

(2013) Beth E. Fisher et al.   NEUROREPORT

Dopaminergic and Clinical Correlates of Pathological Gambling in Parkinson’s Disease: A Case Report

(2013) Mette Buhl Callesen et al.   Frontiers in Behavioral Neuroscience

Positron emission tomography imaging in neurological disorders

(2012) Marios Politis et al.   JOURNAL OF NEUROLOGY

Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson's patients with medication-induced pathological gambling: A [11C] FLB-457 and PET study

(2012) Nicola J. Ray et al.   NEUROBIOLOGY OF DISEASE

[18F]FDG-PET is superior to [123I]IBZM-SPECT for the differential diagnosis of parkinsonism

(2012) S. Hellwig et al.   NEUROLOGY

Serotonin Neuron Loss and Nonmotor Symptoms Continue in Parkinson's Patients Treated with Dopamine Grafts

(2012) M. Politis et al.   Science Translational Medicine

Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours

(2011) S. S. O'Sullivan et al.   BRAIN

Graft-induced dyskinesias in Parkinson's disease: High striatal serotonin/dopamine transporter ratio

(2011) Marios Politis et al.   MOVEMENT DISORDERS

Effects of Expectation on Placebo-Induced Dopamine Release in Parkinson Disease

(2010) Sarah C. Lidstone et al.   ARCHIVES OF GENERAL PSYCHIATRY

Imaging Cortical Dopamine D1 Receptors Using [11C]NNC112 and Ketanserin Blockade of the 5-HT2A Receptors

(2010) Ana M Catafau et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

The Value of the Dopamine D2/3 Receptor Ligand 18F-Desmethoxyfallypride for the Differentiation of Idiopathic and Nonidiopathic Parkinsonian Syndromes

(2010) C. la Fougere et al.   JOURNAL OF NUCLEAR MEDICINE

Serotonergic Neurons Mediate Dyskinesia Side Effects in Parkinson's Patients with Neural Transplants

(2010) M. Politis et al.   Science Translational Medicine

Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease

(2009) I. Boileau et al.   BRAIN

Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study

(2009) T. D. L. Steeves et al.   BRAIN

Understanding the Placebo Effect

(2009)   JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES

Parkinson's disease

(2009) Andrew J Lees et al.   LANCET

The placebo-reward hypothesis: dopamine and the placebo effect

(2009) Raúl de la Fuente-Fernández   PARKINSONISM & RELATED DISORDERS

Impulsive choice and response in dopamine agonist-related impulse control behaviors

(2009) Valerie Voon et al.   PSYCHOPHARMACOLOGY

In vivo quantification of regional dopamine-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic mice

(2009) Eugenii A. Rabiner et al.   SYNAPSE

Cognitive deficits and striato-frontal dopamine release in Parkinson's disease

(2008) Nobukatsu Sawamoto et al.   BRAIN

Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson's disease: An in vivo 11C-raclopride PET study

(2008) Marios Politis et al.   EXPERIMENTAL NEUROLOGY

Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA

(2008) Vanessa L. Cropley et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans

(2007) Ariel Graff-Guerrero et al.   HUMAN BRAIN MAPPING